HDAC5 promotes Mycoplasma pneumoniae-induced inflammation in macrophages through NF-κB activation

Yuehua Zhao1, Guorui Ma1, Xingge Yang1

  • 1Department of Paediatrics, First Subsidiary Hospital, University of Science and Technology of He'nan, 471000, China.

Life Sciences
|February 10, 2019
PubMed

Insights

Histone deacetylase 5 (HDAC5) promotes inflammation in Mycoplasma pneumoniae (MP) respiratory infections. Reduced HDAC5 levels correlate with infection severity, suggesting it plays a key role in MP-induced inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae (MP) infection causes significant respiratory illness in children, driven by excessive inflammation.
  • Histone deacetylase 5 (HDAC5) is implicated in inflammatory processes, but its specific role in MP immunity is unknown.

Purpose of the Study:

  • To investigate the role of HDAC5 in the immune response to Mycoplasma pneumoniae infection.
  • To elucidate the molecular mechanisms by which HDAC5 influences MP-induced inflammation.

Main Methods:

  • Analysis of HDAC5 expression in peripheral blood mononuclear cells (PBMCs) from children with Mycoplasma pneumoniae pneumonia (MPP) and in MP-infected macrophages.
  • Functional studies involving HDAC5 overexpression and depletion in THP-1 macrophages to assess cytokine production.
  • Investigation of HDAC5's effect on NF-κB activation and the impact of NF-κB inhibition on inflammatory responses.

Main Results:

  • HDAC5 expression was decreased in PBMCs of MPP patients and in MP-infected macrophages.
  • HDAC5 overexpression enhanced, while depletion inhibited, MP-induced proinflammatory cytokine production.
  • HDAC5 modulates NF-κB activation in MP-infected macrophages, and NF-κB inhibition reduced HDAC5's pro-inflammatory effect.

Conclusions:

  • HDAC5 promotes Mycoplasma pneumoniae-induced inflammatory responses in macrophages via NF-κB activation.
  • HDAC5 represents a novel factor in MP pathophysiology and a potential target for controlling inflammation in MPP.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
871
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.0K